This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This TIFAB antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 37-66 amino acids from the Central region of human TIFAB.
TIFAB
Reaktivität: Human
WB, ELISA
Wirt: Kaninchen
Polyclonal
HRP
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
TIFAB
(TRAF-Interacting Protein with Forkhead-Associated Domain, Family Member B (TIFAB))
RGD1311681 antikoerper, TIFA inhibitor antikoerper, TRAF-interacting protein with forkhead-associated domain, family member B antikoerper, TIFAB antikoerper, Tifab antikoerper
Hintergrund
TIFAB associates with TIFA (MIM 609028) and inhibits TIFA-mediated activation of NF-kappa-B (NFKB1, MIM 164011) (Matsumura et al., 2004 [PubMed 15047173]).